Central mediation and differential blockade by cannabinergics of the discriminative stimulus effects of the cannabinoid CB1 receptor antagonist rimonabant in rats
Published 2011 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Central mediation and differential blockade by cannabinergics of the discriminative stimulus effects of the cannabinoid CB1 receptor antagonist rimonabant in rats
Authors
Keywords
-
Journal
PSYCHOPHARMACOLOGY
Volume 216, Issue 3, Pages 355-365
Publisher
Springer Nature
Online
2011-03-03
DOI
10.1007/s00213-011-2226-3
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Inverse agonism of cannabinoid CB1 receptors potentiates LiCl-induced nausea in the conditioned gaping model in rats
- (2010) CL Limebeer et al. BRITISH JOURNAL OF PHARMACOLOGY
- A novel peripherally restricted cannabinoid receptor antagonist, AM6545, reduces food intake and body weight, but does not cause malaise, in rodents
- (2010) NL Cluny et al. BRITISH JOURNAL OF PHARMACOLOGY
- Receptors and Channels Targeted by Synthetic Cannabinoid Receptor Agonists and Antagonists
- (2010) R. Pertwee CURRENT MEDICINAL CHEMISTRY
- Antagonism of ∆9-THC induced behavioral effects by rimonabant: Time course studies in rats
- (2010) Torbjörn U.C. Järbe et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Peripheral CB1 cannabinoid receptor blockade improves cardiometabolic risk in mouse models of obesity
- (2010) Joseph Tam et al. JOURNAL OF CLINICAL INVESTIGATION
- Anandamide serves two masters in the brain
- (2010) Vincenzo Di Marzo NATURE NEUROSCIENCE
- The CB1 inverse agonist AM251, but not the CB1 antagonist AM4113, enhances retention of contextual fear conditioning in rats
- (2010) K.S. Sink et al. PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR
- Potential anxiogenic effects of cannabinoid CB1 receptor antagonists/inverse agonists in rats: Comparisons between AM4113, AM251, and the benzodiazepine inverse agonist FG-7142
- (2009) K.S. Sink et al. EUROPEAN NEUROPSYCHOPHARMACOLOGY
- The FAAH inhibitor URB-597 interferes with cisplatin- and nicotine-induced vomiting in the Suncus murinus (house musk shrew)
- (2009) L.A. Parker et al. PHYSIOLOGY & BEHAVIOR
- The endocannabinoid system in brain reward processes
- (2008) M Solinas et al. BRITISH JOURNAL OF PHARMACOLOGY
- Pharmacological and therapeutic secrets of plant and brain (endo)cannabinoids
- (2008) Lumír Ondřej Hanuš MEDICINAL RESEARCH REVIEWS
- Intrinsic effects of AM4113, a putative neutral CB1 receptor selective antagonist, on open-field behaviors in rats
- (2008) T JARBE et al. PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR
- Oral bioavailability of the novel cannabinoid CB1 antagonist AM6527: Effects on food-reinforced behavior and comparisons with AM4113
- (2008) K.S. Sink et al. PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR
- Discriminative stimulus properties of naloxone in Long–Evans rats: assessment with the conditioned taste aversion baseline of drug discrimination learning
- (2008) Catherine M. Davis et al. PSYCHOPHARMACOLOGY
- Discriminative stimulus functions in rats of AM1346, a high-affinity CB1R selective anandamide analog
- (2008) Torbjörn U. C. Järbe et al. PSYCHOPHARMACOLOGY
- Discriminative stimulus effects of the cannabinoid CB1 receptor antagonist rimonabant in rats
- (2008) Torbjörn U. C. Järbe et al. PSYCHOPHARMACOLOGY
- Pharmacotherapeutic targeting of the endocannabinoid signaling system: Drugs for obesity and the metabolic syndrome
- (2007) V. Kiran Vemuri et al. PHYSIOLOGY & BEHAVIOR
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now